Concepedia

Publication | Closed Access

Clinical and Molecular Studies of the Effect of Imatinib on Advanced Aggressive Fibromatosis (desmoid tumor)

315

Citations

28

References

2006

Year

Abstract

Imatinib is an active agent in the treatment of advanced AF. Imatinib response in AF patients may be mediated by inhibition of PDGFRB kinase activity.

References

YearCitations

Page 1